Thyroid Cancer Drugs Market Research Study Including Growth Factors, Types And Application By Regions From 2018 To 2026



In the recent past, increasing number of thyroid cancers were diagnosed at an early stage of the treatment as several new technologies has arrived with drugs. Advanced treatments resulting into long term survival, minimum complications of surgery and improved quality of life in a cost-effective way. The main types of thyroid cancer includes differentiated, medullary, and anaplastic thyroid cancer. Among these, anaplastic thyroid cancer is characterized with an aggressive undifferentiated tumor. Apart from these, the other types of thyroid cancer includes thyroid lymphomas, thyroid sarcomas, parathyroid cancer or other rare thyroid tumors.
Thyroid Cancer Drugs Market Drivers
Increasing prevalence of thyroid cancer is expected to drive growth of the thyroid cancer drugs market. For instance, according to National Cancer Institute (NCI), 2013-2015 data findings, around1.2% of men and women are expected to be diagnosed with thyroid cancer at some point during their lifetime, in the U.S. Moreover, according to the NCI 2018 data findings, in 2018, there were an estimated 53,990 new cases of thyroid cancer and an estimated 2,060 people are expected to die due to thyroid cancer, in the U.S. Moreover, according to Cancer Research UK, 2015 data findings, in the U.K. there were 3,528 new cases of thyroid cancer registered in 2015. According to the same source, thyroid cancer accounted to register 1% of all cancer cases in 2015, which includes 27% of thyroid cancer cases in males, and 73% in females, in the U.K. Furthermore, according to Cancer Research UK, the lifetime risk of developing thyroid cancer is around 1 in 480 for men and around 1 in 180 for women, in 2012 in the U.K.  
Thyroid Cancer Drugs Market - Regional Analysis
Geographically, thyroid cancer drugs market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds the dominant position in thyroid cancer drugs market. This is owing to growing prevalence of thyroid cancer in this region. According to National Cancer Institute (NCI) 2018 data findings, in 2015, there were an estimated 765,547 people living with thyroid cancer in the U.S. Moreover, according to the same source, an estimated 53,990 new cases of thyroid cancer are expected to be registered in 2018, representing 3.1% of all new cancer cases, in 2018.    
Thyroid Cancer Drugs Market Competitive Landscape
Some of the key players operating in thyroid cancer drugs market include Biovista, Vascular Biogenics, Azaya Therapeutics, Bionomics, Bayer, Eisai, Bio-Path Holdings, Takeda Pharmaceutical Company, GlaxoSmithKline plc, and AstraZeneca plc. Key players in the market are focusing on organic growth strategies, in order to enhance its market share and retain its position in the market. For instance, in May 2016, U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for AstraZeneca’s investigational MEK 1/2 inhibitor, selumetinib for adjuvant treatment of patients with stage III or IV differentiated thyroid cancer (DTC). Moreover, in April 2011, FDA approved AstraZeneca’s kinase inhibitor vandetanib for the treatment of unresectable or metastatic medullary thyroid cancer.  
Furthermore, key players are engaged in developing effective drugs to treat thyroid cancer through their diverse range of product pipeline. For instance, in June 2012, Azaya Therapeutics, Inc. announced the Phase I study of their anti-cancer drug, ATI-1123 (liposomal docetaxel), which is also indicated for thyroid cancer treatment. The result shows that 79% of heavily pretreated patients received benefit from ATI-1123. 
Thyroid Cancer Drugs Market Taxonomy:
By Drug Type:
  • Ipilimumab
  • Cabozantinib-S-Malate
  • Caprelsa (Vandetanib)
  • Doxorubicin Hydrochloride
  • Cometriq (Cabozantinib-S-Malate)
  • Lenvatinib Mesylate
  • Nivolumab
  • Vandetanib
  • Others
By End Users:
  • Hospitals
  • Oncology Clinics
  • Research Organizations
  • Others
By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa


About Coherent Market Insights


Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.




Contact Us


Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702


Comments

Post a Comment

Popular posts from this blog

Cosmetic Dentistry Market Enhancement in Various Sector 2018 to 2026

Image
Cosmetic dentistry refers to any dental work that improves the appearance of gums or teeth. It focuses on improving dental aesthetics in size, shape, color, position, and alignment. It involves the addition of dental materials such as porcelain veneers, gum grafts, crowns, and bonding to gums or teeth, removal of teeth structure and gums through procedures such as enameloplasty, gingivectomy, teeth whitening, gum depigmentation, laser whitening, and teeth straightening. Laser whitening is more effective as compared to other procedures for teeth whitening. Bonding in cosmetic dentistry involves the adhesion of a dentistry material onto both surfaces of the tooth, which is then sculpted, hardened, and polished. Dental bridges are used to replace one or more missing teeth. Bridge, which is made up of abutments can consist of over 3 teeth in total and the average life of bridges is 10 years. Veneers are custom made ultra-thin porcelain laminates that are bonded directly to the t...
Read more

Telemedicine Market to Witness Robust Expansion Throughout the Forecast Period 2018-2026

Image
Telemedicine involves the use of information technology and telecommunication for the delivery of healthcare services such as health assessments or consultations over the telecommunications infrastructure. It helps the healthcare professional to diagnose, evaluate and treat patients without the need for an in-person visit and are also very useful to save lives at time of critical care and emergency situations. Telemedicine is of great help for distant rural areas as they help in overcoming the distance barriers to avail medical services at the time of requirement. Telemedicine enables the doctors to be connected through a variety of electronic means, including video conferencing, email and electronic messaging platforms. This reduces the overall cost of medical care for patients and increase healthcare accessibility. Download PDF Brochure Of This Report: https://www.coherentmarketinsights.com/insight/request-pdf/548 Seeing the potential that the telemedicine provid...
Read more